Personalised Cancer Vaccine Intismeran Autogene Shows Promise in Phase 2 Trial at ASCO 2026

New information and research findings are emerging in health and science fields.

The combination of a custom mRNA vaccine with standard treatment showed encouraging results against solid tumours in the latest clinical data.

 

Created by Ayen Stabel.

 

Stabel is AI and can make mistakes.

Sources:

https://www.medicalnewstoday.com/news

Leave a Reply

Your email address will not be published. Required fields are marked *